¼¼°èÀÇ ¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Type (Latex Agglutination Tests, Lateral Flow Assay), By End Use (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1631171
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,443,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,862,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,700,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, IncÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 1¾ï 5,590¸¸ ´Þ·¯¿¡ À̸£¸ç, 2025-2030³â CAGRÀº 3.9%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº Áúº´ÀÇ Á¶±â Áø´Ü¿¡ ´ëÇÑ »ç¶÷µéÀÇ ÀǽÄÀÌ ³ô¾ÆÁö°í °Ë»çÀÇ °íÁ¤¹Ðµµ¿Í ÇÔ²² ½Å¼Ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö±â ¶§¹®ÀÔ´Ï´Ù. °Ô´Ù°¡ Áúº´ ºÎ´ãÀ» ÁÙÀ̱â À§ÇÑ Á¤ºÎ Áö¿ø Áõ°¡¿Í Áø´Ü¼¾ÅÍ Áõ°¡µµ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Àü¿°º´ ¹× HIV À¯Çà Áõ°¡´Â ¼ö¸·¿°ÀÇ ¹ßº´ À§ÇèÀ» Áõ°¡½ÃŰ°í ¼ö¸·¿° Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¼¼°èÀûÀ¸·Î Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î WHO¿¡ µû¸£¸é 2021³â¿¡´Â ¼¼°è¿¡¼­ 3,840¸¸ ¸í ÀÌ»óÀÌ HIV¿¡ °¨¿°µÇ¾ú´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ CDC¿¡ µû¸£¸é 2020³â¿¡´Â ¹Ì±¹¿¡¼­ ¾à 3¸¸ 635¸íÀÌ HIV Áø´ÜÀ» ¹Þ¾Ò½À´Ï´Ù. ¶ÇÇÑ EV ¼ö¸·¿°Àº ¹Ì±¹¿¡¼­ ¸Å³â ¾à 30,000-50,000¸íÀÇ ÀÔ¿øÀ» ÀÏÀ¸Å³ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

µû¶ó¼­ ÀÌ·¯ÇÑ ´ë»ó ÁúȯÀÇ ³ôÀº ¹ß»ý·üÀÌ Á¦Á¶¾÷ü¿¡°Ô Á¤È®ÇÑ Áø´Ü ¼Ö·ç¼ÇÀÇ °³¹ßÀ» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Cepheid´Â ÃÖÀûÀÇ °¨µµ¿Í ƯÀ̵µ·Î 2.5½Ã°£¿¡ °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â °í¼Ó ºÐÀÚü¿Ü Áø´Ü¿ë EV °Ë»çÀÎ Xpert EV¸¦ Á¦°øÇß½À´Ï´Ù. ¸¶Âù°¡Áö·Î Diagenode DiagnosticsÀÇ M-DiaMult´Â PCR-CE-IVD ŰƮÀÇ ÀÏÁ¾À¸·Î ¼ö¸·¿°±ÕÀ» Æ÷ÇÔÇÑ ¸¹Àº ¼¼±Õ °¨¿°À» °ËÃâÇÕ´Ï´Ù.

¼ö¸·¿° °¨¿°Àº Àå±â°£ÀÇ ¿µÇâ°ú ³ôÀº »ç¸Á·ü·Î ÀÎÇØ ¼¼°è ¹®Á¦·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ´Â ¼ö¸·¿°À» ±ÙÀýÇϱâ À§ÇØ Ã·´Ü Áø´Ü Å×½ºÆ®¿Í Ä¡·á ¿ä¹ýÀ» Á¦°øÇÏ´Â Àû±ØÀûÀÎ Áö¿øÀ» ½Ç½ÃÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼ö¸·¿° ¿¬±¸Àç´Ü°ú CDC´Â °áÇÙ, ¸»¶ó¸®¾Æ, ¼ö¸·¿° µî º´¿ø¿¡¼­ ¹ÞÀ» ¼ö ¾ø´Â ´Ù¾çÇÑ °¨¿°ÁõÀÇ Áø´ÜÀ» ¹ßÇ¥Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ´Ù¾çÇÑ °¨¿°ÀÇ Áø´ÜÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°ø ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

°Ô´Ù°¡, ÀÇ·á ºÎ¹® °³¹ßÀÇ ±ÞÁõ°ú Áø´Ü °Ë»çÀÇ ±â¼ú Áøº¸ È®´ë´Â ½ÃÀå¿¡ °­·ÂÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 7¿ù, ºÐÀÚÁø´Ü °Ë»çÀÇ ¸®´õÀÎ Abacus Diagnostica´Â ³ú¿°°ú ¼ö¸·¿°À» À¯¹ßÇÏ´Â ¹ÙÀÌ·¯½º¸¦ ½Å¼ÓÇÏ°Ô È®ÀÎÇϱâ À§ÇÑ »õ·Î¿î ½Å¼Ó PCR °Ë»ç¸¦ À¯·´ ½ÃÀå¿¡¼­ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ »õ·Î¿î Ãâ½Ã °Ë»ç¸¦ ÅëÇØ ÀÇ·á Àü¹®°¡´Â ¼ö¸·¿°À» ÀÏÀ¸Å°´Â °¡Àå ÈçÇÑ ¹ÙÀÌ·¯½º¸¦ 70ºÐ ³»¿¡ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¤È®ÇÏ°í ½Å¼ÓÇÑ °Ë»çÀÇ Ã¤ÅÃÀº ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀå : À¯Çüº° ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ¼ö¸·¿° Áø´Ü °Ë»ç ½ÃÀå :Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 155.9 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.9% from 2025 to 2030. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Meningitis Diagnostic Testing Market Variables, Trends, & Scope

Chapter 4. Meningitis Diagnostic Testing Market: Type Business Analysis

Chapter 5. Meningitis Diagnostic Testing Market: End Use Business Analysis

Chapter 6. Meningitis Diagnostic Testing Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â